Professor, Urology, University of Miami School of Medicine
Urology
Dr. Murugesan Manoharan, MD
|
|
Give Review
Murugesan Manoharan is an expert in the field of Urology. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Murugesan Manoharan is also a published MD. He has 83 paper published. The most recent paper is: Resolution of hypercalcemia of malignancy following radical cystectomy in a patient with paraneoplastic syndrome associated with urothelial carcinoma of the bladder. He accepts all Medicare patients.
Publications
- Pathologic evaluation of non-neoplastic Renal parenchyma in partial nephrectomy specimens.
- Active surveillance vs. treatment for low-risk prostate Cancer: a cost comparison.
- Comparative validation of nomograms predicting clinically insignificant prostate Cancer.
- Biopsy features associated with prostate Cancer progression in active surveillance patients: comparison of three statistical models.
- Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate Cancer progression in active surveillance patients.
- Partial sampling of radical Prostatectomy specimens: detection of positive margins and extraprostatic extension.
- Neoadjuvant and adjuvant chemotherapy for muscle-invasive Bladder cancer: The likelihood of initiation and completion.
- C-X-C chemokine receptor 7: A functionally associated molecular marker for Bladder cancer.
- Surgical margin status does not affect overall survival following radical Prostatectomy: a single institution experience with expectant management.
- Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) over time among men treated for localized prostate Cancer.
- Clinical and demographic characteristics associated with prostate Cancer progression in patients on active surveillance.
- Pathological findings at radical Prostatectomy in patients initially managed by active surveillance: A comparative analysis.
- Resolution of hypercalcemia of malignancy following radical cystectomy in a patient with paraneoplastic syndrome associated with urothelial carcinoma of the Bladder.
- Pelvic lipomatosis: Bladder sparing extirpation of pelvic mass to relieve Bladder storage dysfunction symptoms and pelvic pain.
- UreteroColic fistula secondary to a self-expanding retrievable ureteral stent.
- Renal cell carcinoma with solitary metastasis to the Bladder: mode of spread and prognosis.
- Prostate sampling by 12-core biopsy: comparison of the biopsy results with tumor location in Prostatectomy specimens.
- Oncological and functional outcomes following open radical Prostatectomy: how patients may achieve the "Trifecta"?
- Clinically significant Gleason sum upgrade: external validation and head-to-head comparison of the existing nomograms.
- Endoscopic retrieval of a retained self-expanding metal stent placed for a ureteroileal anastomotic stricture.
- Radical cystectomy for BCG failure: has the timing improved in recent years?
- Careful selection and close monitoring of low-risk prostate Cancer patients on active surveillance minimizes the need for treatment.
- Does previous robot-assisted radical Prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy C...
- Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant Prostate disease.
- Reply from authors re: Urs E. Studer, Laurence Collette. Robot-assisted cystectomy: does it meet expectations? Eur Urol 2010;58:203-4.
- Robotic-assisted radical cystectomy and orthotopic ileal neoBladder using a modified Pfannenstiel incision.
- Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
- Resolution of Thrombocytopenia Secondary to Disseminated Intravascular Coagulation With Docetaxel Chemotherapy in Prostate Cancer.
- Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
- The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
- Small cell carcinoma of the Bladder in transplant recipients: a report of 2 cases.
- Role of patient-physician dialogue in selecting the type of urinary diversion.
- Contemporary open partial nephrectomy is associated with diminished procedure-Specific morbidity despite increasing technical challenges: a single institutional experi...
- "Complete transurethral resection of Bladder tumor": are the guidelines being followed?
- Brachytherapy-based Bladder sparing alternative to cystectomy.
- Synchronous panniculectomy with stomal revision for obese patients with stomal stenosis and retraction.
- Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?
- Total Prostatectomy and lymph node dissection may be done safely without pelvic drainage: an extended experience of over 600 cases.
- Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases?
- Incisional hernia involving the neoBladder: technical considerations to avoid complications.
- A rare case of Renal gastrinoma.
- Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience.
- Radical cystectomy for urothelial carcinoma of the Bladder: an analysis of perioperative and survival outcome.
- Role of maximum androgen blockade in advanced prostate Cancer.
- Outcome after radical cystectomy in patients with clinical T2 Bladder cancer in whom neoadjuvant chemotherapy has failed.
- The role of liver transplantation techniques in the surgical management of advanced Renal urothelial carcinoma with or without inferior vena cava thrombus.
- En bloc mobilization of the pancreas and spleen to facilitate resection of large tumors, primarily Renal and adRenal, in the left upper quadrant of the abdomen: techni...
- Are patients with Hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey.
- Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter.
- Delayed local recurrence following radiation therapy for muscle-invasive Bladder cancer emphasizing the need for lifelong surveillance: a case report.
- Trends in Gleason score: concordance between biopsy and Prostatectomy over 15 years.
- Factors affecting erectile function after radical retropubic Prostatectomy: results from 1620 consecutive patients.
- Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy.
- Active surveillance; a reasonable management alternative for patients with prostate Cancer: the Miami experience.
- Prostatic involvement by urothelial carcinoma of the Bladder: clinicopathological features and outcome after radical cystectomy.
- The role of the surgeon and transurethral resection in the treatment of superficial Bladder cancer.
- The emerging role of epigenetics in urological Cancers.
- Intraoperative cell salvage during radical cystectomy does not affect long-term survival.
- Basal cell carcinoma of the Prostate: current concepts.
- Does body mass index affect outcome after reconstruction of orthotopic neoBladder?
- Epigenetic targets in the diagnosis and treatment of prostate Cancer.
- Lack of progress in early diagnosis of Bladder cancer.
- HAS1 expression in Bladder cancer and its relation to urinary HA test.
- Orthotopic ileal neoBladder reconstruction for Bladder cancer: is adjuvant chemotherapy safe?
- Adrenocortical carcinoma with tumor thrombus in the right hepatic vein.
- Concurrent radical retropubic Prostatectomy and Lichtenstein inguinal hernia repair through a single modified Pfannenstiel incision: a 3-year experience.
- A pelvic drain can often be avoided after radical retropubic Prostatectomy--an update in 552 cases.
- Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial Bladder preservation.
- Bladder cancer: epidemiology, staging and grading, and diagnosis.
- Is adjuvant chemotherapy for Bladder cancer safer in patients with an ileal conduit than a neoBladder?
- Venous thromboembolism in radical Prostatectomy: is heparinoid prophylaxis warranted?
- Management of neoBladder-vaginal fistula and stress incontinence following radical cystectomy in women: a review.
- Polymorphisms in the DNA methyltransferase 3b gene and prostate Cancer risk.
- Optimal management of the T1G3 Bladder cancer.
- Intraoperative cell salvage during radical Prostatectomy is not associated with greater biochemical recurrence rate.
- Standard reconstruction techniques: techniques of ureteroneocystostomy during urinary diversion.
- Evaluation of analgesic requirements and postoperative recovery after radical retropubic Prostatectomy using long-acting spinal anesthesia.
- Neither alpha-blocker therapy nor cystography is required before early catheter removal after radical Prostatectomy.
- Intraoperative cell salvage during radical Prostatectomy: a safe technique for Jehovah''s Witnesses.
- Urethral recurrence after cystoProstatectomy: implications for urinary diversion and monitoring.
- Upper tract tumour after radical cystectomy for transitional cell carcinoma of the Bladder: incidence and risk factors.
- Spontaneous rupture of Bladder presenting as peritonitis.
Schools
Madras Medical College Tamil Nadu Dr Mgr Medical University
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystometry
- View All
Conditions Treated
- Bedwetting
- Bladder Atony
- Bladder Cancer
- Bladder Infection
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System
Drug Facts
| NPI NUMBER | 1679502256 | |
| NPPES Provider LastName | MANOHARAN | |
| NPPES Provider FirstName | MURUGESAN | |
| NPPES Provider ZIPCode | 331361005 | |
| NPPES Provider State | FL | |
| Specialty Description | Urology | |
| Total Claim Count | 815.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 120.0 | |
| Percent Opioid Claims | 14.72 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679502256 |
| Last Name Of The Provider | MANOHARAN |
| First Name Of The Provider | MURUGESAN |
| View All |
Similar Doctors
|
|
Dr. Guarionex R. De Castro, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Eduardo Garcia Montes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith F. Russell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Daughtry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard C. Davi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramgopal Satyanarayana Konanur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wynne A. Steinsnyder, DO |
|
|
Dr. Juan J. Chipollini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacob Cohen, MD |
|
|
Dr. Elie Antebi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott M. Castle, MD |
|
|
Dr. Jose A. Perez, MD |
|
|
Dr. Luis F. Sabogal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Shields, MD |
|
Dr. Robert W. Santa-Cruz, MD
This Doctor is OpenDoctor Recommended.
|